DAVID POPLACK to Soft Tissue Neoplasms
This is a "connection" page, showing publications DAVID POPLACK has written about Soft Tissue Neoplasms.
Connection Strength
0.043
-
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol. 1996 Feb; 14(2):362-72.
Score: 0.027
-
Late soft tissue recurrence of acute lymphoblastic leukemia in a site of antecedent trauma. J Pediatr. 1978 May; 92(5):849-50.
Score: 0.008
-
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Clin Cancer Res. 1998 Feb; 4(2):357-60.
Score: 0.008